295 related articles for article (PubMed ID: 17251422)
1. Disturbed cross talk between insulin-like growth factor I and AMP-activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein/presenilin 2 mouse model of Alzheimer's disease.
Lopez-Lopez C; Dietrich MO; Metzger F; Loetscher H; Torres-Aleman I
J Neurosci; 2007 Jan; 27(4):824-31. PubMed ID: 17251422
[TBL] [Abstract][Full Text] [Related]
2. The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease.
Spuch C; Antequera D; Portero A; Orive G; Hernández RM; Molina JA; Bermejo-Pareja F; Pedraz JL; Carro E
Biomaterials; 2010 Jul; 31(21):5608-18. PubMed ID: 20430437
[TBL] [Abstract][Full Text] [Related]
3. Acceleration of amyloidogenesis and memory impairment by estrogen deficiency through NF-κB dependent beta-secretase activation in presenilin 2 mutant mice.
Hwang CJ; Park MH; Choi MK; Choi JS; Oh KW; Hwang DY; Han SB; Hong JT
Brain Behav Immun; 2016 Mar; 53():113-122. PubMed ID: 26593275
[TBL] [Abstract][Full Text] [Related]
4. Early hippocampal hyperexcitability in PS2APP mice: role of mutant PS2 and APP.
Fontana R; Agostini M; Murana E; Mahmud M; Scremin E; Rubega M; Sparacino G; Vassanelli S; Fasolato C
Neurobiol Aging; 2017 Feb; 50():64-76. PubMed ID: 27889678
[TBL] [Abstract][Full Text] [Related]
5. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
Zhang B; Tang XC; Zhang HY
J Neurosci Res; 2013 May; 91(5):717-25. PubMed ID: 23401344
[TBL] [Abstract][Full Text] [Related]
6. The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.
Kim B; Elzinga SE; Henn RE; McGinley LM; Feldman EL
Neurobiol Dis; 2019 Dec; 132():104541. PubMed ID: 31349033
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis.
Carro E; Trejo JL; Gerber A; Loetscher H; Torrado J; Metzger F; Torres-Aleman I
Neurobiol Aging; 2006 Sep; 27(9):1250-7. PubMed ID: 16183170
[TBL] [Abstract][Full Text] [Related]
8. Dampened Slow Oscillation Connectivity Anticipates Amyloid Deposition in the PS2APP Mouse Model of Alzheimer's Disease.
Leparulo A; Mahmud M; Scremin E; Pozzan T; Vassanelli S; Fasolato C
Cells; 2019 Dec; 9(1):. PubMed ID: 31878336
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
10. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
11. Presenilin dependence of phospholipase C and protein kinase C signaling.
Dehvari N; Cedazo-Minguez A; Isacsson O; Nilsson T; Winblad B; Karlström H; Benedikz E; Cowburn RF
J Neurochem; 2007 Aug; 102(3):848-57. PubMed ID: 17437536
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease.
Matsuura Y; Ueda M; Higaki Y; Sano K; Saji H; Enomoto S
Mol Imaging Biol; 2019 Jun; 21(3):519-528. PubMed ID: 30047036
[TBL] [Abstract][Full Text] [Related]
13. Presenilin 2 mutation accelerates the onset of impairment in trace eyeblink conditioning in a mouse model of Alzheimer's disease overexpressing human mutant amyloid precursor protein.
Kishimoto Y; Kirino Y
Neurosci Lett; 2013 Mar; 538():15-9. PubMed ID: 23370287
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
Wang D; Liu X; Liu Y; Li S; Wang C
J Alzheimers Dis; 2017; 59(4):1255-1267. PubMed ID: 28731433
[TBL] [Abstract][Full Text] [Related]
15. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic stress, brain vascular system, and β-amyloid: a primary cell culture study.
Muche A; Bürger S; Arendt T; Schliebs R
Nutr Neurosci; 2015 Jan; 18(1):1-11. PubMed ID: 24257464
[TBL] [Abstract][Full Text] [Related]
17. Circulating Insulin-Like Growth Factor I is Involved in the Effect of High Fat Diet on Peripheral Amyloid β Clearance.
Herrero-Labrador R; Trueba-Saiz A; Martinez-Rachadell L; Fernandez de Sevilla ME; Zegarra-Valdivia JA; Pignatelli J; Diaz-Pacheco S; Fernandez AM; Torres Aleman I
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352990
[TBL] [Abstract][Full Text] [Related]
18. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
19. AMPK activation inhibits the expression of HIF-1alpha induced by insulin and IGF-1.
Treins C; Murdaca J; Van Obberghen E; Giorgetti-Peraldi S
Biochem Biophys Res Commun; 2006 Apr; 342(4):1197-202. PubMed ID: 16516166
[TBL] [Abstract][Full Text] [Related]
20. Calcium Signaling and Mitochondrial Function in Presenilin 2 Knock-Out Mice: Looking for Any Loss-of-Function Phenotype Related to Alzheimer's Disease.
Rossi A; Galla L; Gomiero C; Zentilin L; Giacca M; Giorgio V; Calì T; Pozzan T; Greotti E; Pizzo P
Cells; 2021 Jan; 10(2):. PubMed ID: 33494218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
